Brain fog and other symptoms of 'chronic COVID' have impacted the health and lives of millions. According to the Associated Press, in this context, the U.S. National Institutes of Health is beginning studies to test potential treatments for chronic COVID, known as 'long COVID,' which represents a hopeful step in the United States' efforts to combat this mysterious disease that has infected millions. Scientists still do not know what causes chronic COVID, which has about 200 completely different symptoms. It is estimated that between 10 to 30 percent of those infected may experience some form of chronic COVID after recovering from a coronavirus infection, a condition that has somewhat decreased since the early days of the pandemic. In these studies, 24,000 patients are being monitored to identify the most common and severe symptoms of chronic COVID. These findings could be useful in multi-faceted therapeutic trials. Researchers will initially focus on two aspects: whether taking up to 25 days of the antiviral drug 'Paxlovid,' manufactured by Pfizer, can reduce chronic COVID symptoms. The rationale for this test is based on the theory that some live coronavirus or remnants may hide in the body and cause these disorders. Paxlovid is typically used to treat individuals who are newly infected with COVID-19, and only for 5 days. Treatment for 'brain fog' and other cognitive issues will include cognitive training from 'Posit Science,' an American company providing brain training software and services. Another experimental treatment called 'Cognitive Recovery from Acute SARS-CoV-2 Infection' will be implemented by the Mount Sinai Health System in New York. Additionally, a medical device manufactured by 'Satrix' that electrically stimulates brain circuits will be tested. Two other studies will also begin in the coming months, one of which will test treatments for sleep problems, and the other will focus on issues related to the autonomic nervous system, which controls unconscious functions like breathing and heart rate. A more controversial study will examine resilience to exercise and excessive fatigue. In this study, the National Institutes of Health is seeking opinions from some patients who are concerned that exercise may be harmful for some chronic COVID sufferers. The U.S. government: We will not give another dollar to the Wuhan Institute of Virology. Elon Musk linked the cardiac arrest of a basketball star's son to the COVID vaccine. A new U.S. intelligence report on the origins of COVID; the lab leak hypothesis has not yet been ruled out. New research: 10 percent of 'Omicron' patients in the U.S. suffer from chronic COVID. Experts warn; there is a possibility of a return of diseases similar to Omicron.
New Studies by the U.S. National Institutes of Health on Treating Chronic COVID Symptoms
The U.S. National Institutes of Health is launching studies to explore potential treatments for chronic COVID, affecting millions with symptoms like brain fog. With 24,000 patients monitored, researchers aim to identify severe symptoms and test antiviral drugs like Paxlovid. This research is crucial as chronic COVID remains a significant health issue post-pandemic.
👥 Key Players
📰 What Happened
The U.S. National Institutes of Health has initiated studies to explore treatments for chronic COVID, involving 24,000 patients. They are testing the effectiveness of Paxlovid and other therapies on symptoms like brain fog.
- 24,000 patients are being monitored for chronic COVID symptoms.
- Studies include testing Paxlovid for up to 25 days and cognitive training for brain fog.
💡 Why It Matters
📚 Background
Chronic COVID, or 'long COVID,' affects a significant portion of those who recover from COVID-19, with symptoms persisting long after the initial infection.
🏷️ Entities Mentioned
Translated from the original and edited for English readers. View original source →
Translation confidence: 85%